Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Health Institutes of Turkey
Sun Yat-sen University
Karyopharm Therapeutics Inc
Incyte Corporation
Nektar Therapeutics
Sohag University
TG Therapeutics, Inc.
Fondazione Italiana Linfomi - ETS
Gilead Sciences
Roswell Park Cancer Institute
Celgene
Nanfang Hospital, Southern Medical University
Xinjiang Medical University
European Organisation for Research and Treatment of Cancer - EORTC
Probiomed S.A. de C.V.
Lymphoma Study Association